Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy (Q43974789)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 April 2002

Language	Label	Description	Also known as
English	Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy	scientific article published on 22 April 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Geneviève Chêne

9

object named as

Geneviève Chêne

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Catherine Leport

8

object named as

Catherine Leport

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

François Raffi

2

object named as

François Raffi

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Marianne Savès

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jacqueline Capeau

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Willy Rozenbaum

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jean-Marie Ragnaud

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Christian Perronne

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Arnaud Basdevant

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Antiprotéases Cohorte (APROCO) Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

22 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1396-1405

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Metabolic effects of indinavir in healthy HIV-seronegative men

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Hypertriglyceridemia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Lipodystrophies

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Antiretroviral therapy-associated hyperlipidaemia in HIV disease

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Blood lipids of patients with chronic hepatitis: differences related to viral etiology

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

1 reference

https://api.crossref.org/works/10.1086%2F339866

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43974789&oldid=2105196618"